Effects of donepezil (Aricept) on the rapid eye movement sleep of normal subjects

Psychiatry and Clinical Neurosciences

Volumn 56, Issue 3, 2002, Pages 307-308

  Kanbayashi, T ^a   Sugiyama, T ^a   Aizawa, R ^b   Saito, Y ^a   Ogawa, Y ^a   Kitajima, T ^c   Kaneko, Y ^a   Abe, M ^a   Shimizu, T ^a  

^a AKITA UNIVERSITY   (Japan)

^b The Japanese Red Cross Junior College of Akita   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Aricept; Donepezil; Human; Polysomnography; Rapid eye movement sleep

Indexed keywords

DONEPEZIL; PLACEBO;

ADAPTATION; ADULT; ALZHEIMER DISEASE; CHOLINERGIC NERVE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSURIA; ENZYME INHIBITION; HUMAN; LATENT PERIOD; MALE; POLYSOMNOGRAPHY; REM SLEEP; RISK ASSESSMENT; XEROSTOMIA;

ADULT; CHOLINESTERASE INHIBITORS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; INDANS; MALE; PIPERIDINES; POLYSOMNOGRAPHY; SLEEP, REM;

EID: 0036317679     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1819.2002.01008.x     Document Type: Conference Paper

References (6)

1. Cholinesterase inhibitors: A therapeutic strategy for Alzheimer disease
2. The acetylcholinesterase inhibitor di-isopropyl-fluorophosphate increases REM sleep in rats
3. Pharmacological aspects of human and canine narcolepsy
4. Donepezil-induced REM sleep augmentation enhances memory performance in elderly, healthy persons
5. Anti-cholinesterase drug donepezil increases REM sleep duration in Alzheimer's disease patients: Preliminary data
6. The value of REM sleep parameters in differentiating Alzheimer's disease from old-age depression and normal aging